« Return to News | Ethics/Regulatory

AAHRPP's Revised Standards Available for Comment

Thursday, June 4, 2009 07:13 AM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) released revised accreditation standards June 1--the first major revision since the organization established the standards in 2001.

The revised standards, used to measure the ethics and quality of research involving human participants, are available for public comment on AAHRPP's web site. AAHRPP released the proposed standards a month earlier than planned and hopes to publish the final standards by October 1, depending on the number of comments that the organization receives. If all goes as scheduled, organizations applying for accreditation will begin using the new standards in March 2010.

As part of the revision process, AAHRPP has reorganized and clarified some elements, consolidated redundant elements, and expanded elements to include transnational research, conflict of interest, community-based participatory research and data monitoring. By combining some standards and elements, AAHRPP reduced the number of domains from five to three, the number of standards from 22 to 15 and the number of elements from 77 to 65.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.